Wei Chen1, Ming-Juan Hu2, Xiao-Lan Zhong3, Lin-Hua Ji1, Jian Wang4, Cheng-Fang Zhang1, Rui Zhang5, Hao-Ming Lin5. 1. Department of Oncology, People's Hospital of Huadu District, Guangzhou, China. 2. Department of Pathology, People's Hospital of Huadu District, Guangzhou, China. 3. Department of Gastroenterology, People's Hospital of Huadu District, Guangzhou, China. 4. Department of Interventional Medicine, People's Hospital of Huadu District, Guangzhou, China. 5. HBP Surgery Department, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Abstract
BACKGROUND: Many studies have indicated that autophagy plays an important role in multiple cancers, including hepatocellular carcinoma (HCC). This study aimed to establish a prognostic signature for HCC based on autophagy-related genes (ARGs) to predict the prognosis of patients. METHODS: The list of ARGs was derived from screening National Center for Biotechnology Information (NCBI)-Gene and Molecular Signatures Database (MSigDB) datasets. Differential analysis was conducted via the R limma package in HCC patients based on The Cancer Genome Atlas (TCGA) database. Univariate and multivariate Cox regression analysis were conducted to identify key prognostic ARGs via the survival package. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were performed by clusterProfiler package. The Estimation of Stromal and Immune cells in MAlignant Tumor tissues using Expression data (ESTIMATE) algorithm was used to conduct immune analysis. Finally, the correlation between the prognostic model and clinical characteristics was also assessed, including age, tumor-node-metastasis (TNM) stages, and tumor grades. RESULTS: Firstly, 106 differential ARGs were identified and 10 candidates were further confirmed via Cox regression analysis, including BAMBI, HIF1A, SERPINE1, EZH2, SLC9A3R1, IGFBP3, HSPB8, DAB2, CXCL1 and PRNP. The receiver operating characteristic (ROC) curve analysis revealed that the ARGs risk model had a well diagnostic positive rate with 1-year area under the curve (AUC) =0.688 and 3-year AUC =0.674. Correlation analysis indicated that only advanced tumor stages were positively associated with high ARGs scores with P=0.0227. There were also significant differences in tumor purity (P=6.71e-05), infiltrating cell analysis (P=7.77e-05), immune analysis (P=7.9e-05), and stromal cells analysis (P=0.0015) in high- and low-risk ARGs samples. The genes HIF1A, IGFBP3, and DAB2 were found to have high frequent missense mutations in samples with high-risk ARGs scores. Lastly, we also established a nomogram to predict overall survival (OS) of HCC by integrating ARGs scores and other clinical parameters. CONCLUSIONS: Our study established an autophagy-related signature for predicting the prognosis of HCC patients, providing a thorough understanding of the underlying mechanisms of autophagy in HCC. 2021 Journal of Gastrointestinal Oncology. All rights reserved.
BACKGROUND: Many studies have indicated that autophagy plays an important role in multiple cancers, including hepatocellular carcinoma (HCC). This study aimed to establish a prognostic signature for HCC based on autophagy-related genes (ARGs) to predict the prognosis of patients. METHODS: The list of ARGs was derived from screening National Center for Biotechnology Information (NCBI)-Gene and Molecular Signatures Database (MSigDB) datasets. Differential analysis was conducted via the R limma package in HCC patients based on The Cancer Genome Atlas (TCGA) database. Univariate and multivariate Cox regression analysis were conducted to identify key prognostic ARGs via the survival package. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were performed by clusterProfiler package. The Estimation of Stromal and Immune cells in MAlignant Tumor tissues using Expression data (ESTIMATE) algorithm was used to conduct immune analysis. Finally, the correlation between the prognostic model and clinical characteristics was also assessed, including age, tumor-node-metastasis (TNM) stages, and tumor grades. RESULTS: Firstly, 106 differential ARGs were identified and 10 candidates were further confirmed via Cox regression analysis, including BAMBI, HIF1A, SERPINE1, EZH2, SLC9A3R1, IGFBP3, HSPB8, DAB2, CXCL1 and PRNP. The receiver operating characteristic (ROC) curve analysis revealed that the ARGs risk model had a well diagnostic positive rate with 1-year area under the curve (AUC) =0.688 and 3-year AUC =0.674. Correlation analysis indicated that only advanced tumor stages were positively associated with high ARGs scores with P=0.0227. There were also significant differences in tumor purity (P=6.71e-05), infiltrating cell analysis (P=7.77e-05), immune analysis (P=7.9e-05), and stromal cells analysis (P=0.0015) in high- and low-risk ARGs samples. The genes HIF1A, IGFBP3, and DAB2 were found to have high frequent missense mutations in samples with high-risk ARGs scores. Lastly, we also established a nomogram to predict overall survival (OS) of HCC by integrating ARGs scores and other clinical parameters. CONCLUSIONS: Our study established an autophagy-related signature for predicting the prognosis of HCC patients, providing a thorough understanding of the underlying mechanisms of autophagy in HCC. 2021 Journal of Gastrointestinal Oncology. All rights reserved.
Entities:
Keywords:
Autophagy-related genes (ARGs); The Cancer Genome Atlas (TCGA); hepatocellular carcinoma (HCC); prognosis
Authors: Hongping Zheng; Yotsawat Pomyen; Maria Olga Hernandez; Caiyi Li; Ferenc Livak; Wei Tang; Hien Dang; Tim F Greten; Jeremy L Davis; Yongmei Zhao; Monika Mehta; Yelena Levin; Jyoti Shetty; Bao Tran; Anuradha Budhu; Xin Wei Wang Journal: Hepatology Date: 2018-05-09 Impact factor: 17.425
Authors: Jiali Yu; Michael D Green; Shasha Li; Yilun Sun; Sara N Journey; Jae Eun Choi; Syed Monem Rizvi; Angel Qin; Jessica J Waninger; Xueting Lang; Zoey Chopra; Issam El Naqa; Jiajia Zhou; Yingjie Bian; Long Jiang; Alangoya Tezel; Jeremy Skvarce; Rohan K Achar; Merna Sitto; Benjamin S Rosen; Fengyun Su; Sathiya P Narayanan; Xuhong Cao; Shuang Wei; Wojciech Szeliga; Linda Vatan; Charles Mayo; Meredith A Morgan; Caitlin A Schonewolf; Kyle Cuneo; Ilona Kryczek; Vincent T Ma; Christopher D Lao; Theodore S Lawrence; Nithya Ramnath; Fei Wen; Arul M Chinnaiyan; Marcin Cieslik; Ajjai Alva; Weiping Zou Journal: Nat Med Date: 2021-01-04 Impact factor: 53.440
Authors: Neel Shah; Ping Wang; John Wongvipat; Wouter R Karthaus; Wassim Abida; Joshua Armenia; Shira Rockowitz; Yotam Drier; Bradley E Bernstein; Henry W Long; Matthew L Freedman; Vivek K Arora; Deyou Zheng; Charles L Sawyers Journal: Elife Date: 2017-09-11 Impact factor: 8.140